Search Clinical Trials at Baptist Health

Service

Condition

Physician or Investigator

Locations

Recruiting Clinical Trials

Found 35 results for Cancer

Cancer

Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anat
A011801: The COMPASSHER2 Trials (Comprehensive Use Of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T=

Locations: Corbin, Lexington

View Details
Cancer

Breast Cancer
NATALEE: A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant treatment in patients with HR+/HER2- Early Breast Cancer

Locations: Floyd

View Details
Cancer

Breast Cancer
EA1181: Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response Part 1 Component of: The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer)

Locations: Corbin, Floyd, Lexington, Louisville

View Details
Cancer

Breast Cancer
TOL2506A: A Phase 3, Single Arm, Open-Label Study Evaluating Ovarian Suppression Following Three-Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination with Endocrine Therapy in Premenopausal Subjects with Hormone-Receptor Positive

Locations: Lexington, Louisville

View Details
Cancer

Breast Cancer (WIRB-22-0111)
Tropion 02: A Phase 3, Open-label, Randomized Study of Datopotamab Deruxtecan (Dato-DXd) Versus Investigator’s Choice of Chemotherapy in Patients who are not Candidates for PD-1/PD-L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast02).

Locations: Lexington

View Details
Cancer

Breast Cancer (WIRB-23-0134)
TOL2506A-EXT: Open-label, Safety Extension Study for Subjects with Hormone-Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Who Have Completed the OVarian Suppression Evaluating Subcutaneous LeuprolIde Acetate in Breast Cancer (OVELIA) Study.

Locations: Louisville

View Details
Cancer

Carcinoma, Non-Small-Cell Lung
Pacific 4: A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab with Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative NSCLC

Locations: Floyd, Hardin

View Details
Cancer

Cervical Cancer
GOG-3043: A Randomized Controlled Trial of Robotic versus Open Radical Hysterectomy for Cervical Cancer (ROCC trial)

Locations: Lexington

View Details
Cancer

Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
GI005: Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)

Locations: Louisville

View Details
Cancer

Colorectal Cancer
NRG-GI004: This randomized phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread to other places

Locations: Corbin, Lexington

View Details

Suggested Searches

Filter Listings

Service

Condition

Physician or Investigator

Locations

Clinical Trials

Search for Recruiting Clinical Trials

Filter Listings

Service

Condition

Physician or Investigator

Locations